leisure time -WSS

leisure time

author：explore 2025-09-06 07:17:32 - browse：32

Kevin Sayer, CEO of Dexcom Dexcom

For years, diabetes tech company Dexcom has been striving to get its continuous glucose monitors into the hands of type 2 diabetes patients. Last week at the American Diabetes Association’s conference, the company unveiled plans for software built entirely for these patients, including ones who don’t take insulin.

“We’ve been so focused on things that match the needs of somebody who manages diabetes every minute of every day, and insulin delivery,” Kevin Sayer, CEO of Dexcom, told STAT. “This new product is going to be designed to address the needs of somebody with diabetes who’s not doing that, who has type 2 diabetes and is on other drugs.”

Continuous glucose monitoring is already well-established among people with type 1 diabetes, who rely on constant insulin therapy. The technology, which helps patients noninvasively monitor their blood sugar levels and control their insulin pump in real time, has grown rapidly in use over the years, culminating in a $5 billion market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Bird flu outbreak in cows is latest avian flu curveball

WSS

Melinda French Gates resigns from Gates Foundation

After traumatic brain injury, life support decisions can use more time

Trader Joe's recalls 10K cases of broccoli cheddar soup over potential foreign material

Element Biosciences CEO lays out genome sequencing strategy

American Airlines has a tentative contract deal with its pilots. Southwest is still negotiating

Element Biosciences CEO lays out genome sequencing strategy

hotspot

leisure time

focus

Continuity nursing helped my family in our darkest PICU moments

Behind warning on Apellis’s eye drug lies a conflict of interest

Tori Bowie and the unacceptable rates of Black maternal death

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

How one medical school became remarkably diverse

Element Biosciences CEO lays out genome sequencing strategy

Drug repurposing or repositioning? The language matters

MultiPlan and major insurers sued for alleged medical price

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Public health communication lessons from Covid

focus

Ending health disparities requires full federal government, panel says

Public health communication lessons from Covid

Cue Health's Covid

VC firm RA Capital starts a new synthetic biology incubator

‘We were in the air.’ Mississippi family recounts surviving tornado that tore mobile home apart

Biden announces an advanced cancer research initiative

explore

focus

focus

Wikipedia